1. National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou 215123, China
2. Biomedical Basic Research Center (BBRC) of Jiangsu Province, Suzhou 215123, China
Yuting Ma, Huijian Zhang.
Neural–immune tango in cancer: PNS and CNS as emerging conductors of cancer immunosurveillance.
MedScience DOI:10.1007/s11684-026-1269-0
Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med2004; 10(8): 789–799
[2]
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell2011; 144(5): 646–674
[3]
Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov2022; 12(1): 31–46
[4]
Bates A, Fletcher NE, Gao F, Pereira Pinho M, Dong T. Leveraging T cells for cancer immunotherapy. Immun Inflamm2025; 1(1): 9
[5]
Cao Y. Mechanistic understanding of crosstalk between blood vessels and immunity and inflammation in diseases. Immun Inflamm2026; 2(1): 6
[6]
Kienle G, Kiene H. From reductionism to holism: systems-oriented approaches in cancer research. Glob Adv Health Med2012; 1(5): 68–77
[7]
Winkler F, Heuer S, Althammer F, Augustin H, Beleggia F, Demir IE, Koenig J, Kuner R, Kuner T, Loges S, Platten M, Reinhardt HC, Rich JM, Sahm F, Stassart RM, Thiel V, Trumpp A, Venkataramani V, Wick W, Karreman MA. Cancer neuroscience: the past, the present, and the road ahead. Cell2026; 189(8): 2464–2489
[8]
Ma Y, Kroemer G. The cancer-immune dialogue in the context of stress. Nat Rev Immunol2024; 24(4): 264–281
[9]
Amit M, Eichwald T, Roger A, Anderson J, Chang A, Vermeer PD, Dixon KO, Scheff NN, Talbot S. Neuro-immune cross-talk in cancer. Nat Rev Cancer2025; 25(8): 573–589
[10]
Pu T, Sun J, Ren G, Li H. Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications. Signal Transduct Target Ther2025; 10(1): 176
[11]
Zhang P, Miao J, Yu H, Yu H, Liu C, Zhao L, Yang P, Zhou T, Zhang B.. Sympathetic–epithelial crosstalk governs tissue-resident memory T cell immunosurveillance in the skin.. Cell2026; 189(5): 1323–1340 e25
[12]
Wei HK, Yu CD, Hu B, Zeng X, Ichise H, Li L, Wang Y, Wang RL, Germain RN, Chang RB, Jin C. Tumour–brain crosstalk restrains cancer immunity via a sensory–sympathetic axis. Nature2026; 650(8103): 1007–1016
[13]
Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, Gutmann DH, Hervey-Jumper S, Kuner T, Mabbott D, Platten M, Rolls A, Sloan EK, Wang TC, Wick W, Venkataramani V, Monje M. Cancer neuroscience: state of the field, emerging directions. Cell2023; 186(8): 1689–1707
[14]
Huang Q, Hu B, Zhang P, Yuan Y, Yue S, Chen X, Liang J, Tang Z, Zhang B. Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment. Mol Cancer2025; 24(1): 24
[15]
Ng L, Xiao F, Deng C, Lu L. Emerging roles of immune cell-derived neurotransmitters in immunity and disease. Immun Inflamm2026; 2(1): 11